Condensed Balance Sheets - USD ($)	Mar. 31, 2023	Dec. 31, 2022
Current Assets
Cash and Cash Equivalents	$ 31,955	$ 13,377
Inventory	33,598	34,730
Prepaid and other current assets	15,248	22,932
Total current assets	80,801	71,039
Deferred offering costs	187,668	243,039
Patents, net	35,438	36,450
TOTAL ASSETS	303,907	350,528
Current Liabilities
Accounts payable and accrued expenses	1,223,875	1,255,232
Accrued liabilities - related parties	158,960	172,579
Accrued litigation settlement	200,000	300,000
Promissory note payable	10,000	9,136
Loans payable - related parties	4,000	4,000
Convertible notes payable, net of debt discount	199,040	196,177
Convertible notes payable - related party, net of debt discount	484,243	478,331
Total current liabilities	2,280,118	2,415,455
TOTAL LIABILITIES	2,280,118	2,415,455
Commitments and Contingencies	0	0
Stockholders' Deficit
Common Stock - $0.001 par value, 300,000,000 shares Authorized, 236,593,534 and 230,871,034 shares issued and outstanding at March 31, 2023 and December 31, 2022	236,594	230,871
Subscription Receivable	(71,717)	(50,550)
Additional Paid-In Capital	73,077,561	71,830,695
Accumulated Deficit	(75,218,649)	(74,075,943)
Total Stockholders' Deficit	(1,976,211)	(2,064,927)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	303,907	350,528
Series A Convertible Preferred Stock [Member]
Stockholders' Deficit
Series A Convertible Preferred Stock - $0.001 par value, 1,000,000 shares Authorized and 0 shares issued and outstanding	$ 0	$ 0